ANNUAL REPORT 2021 255 FINANCIAL STATEMENTS NOTES TO THE FINANCIAL STATEMENTS ʹˢ˥ ˧˛˘ Ѓˡ˔ˡ˖˜˔˟ ˬ˘˔˥ ˘ˡ˗˘˗ ʦʤ ʷ˘˖˘ˠ˕˘˥ ʥʣʥʤ (CONT’D) 49. SIGNIFICANT EVENTS DURING THE FINANCIAL YEAR (CONT’D) (r) On 25 June 2021, MYEG signed a Letter of Intent (“LOI”) with Zhifei to purchase 10 million doses of Zhifei’s vaccine pursuant to the receipt of a Letter of No Objection (“Letter”) from the Government dated 21 June 2021 for the Company to purchase Zhifei’s vaccine. The Letter was granted by the Government subject to Zhifei’s vaccine meeting all the rules, regulations and licensing requirements imposed by the Government and obtaining the conditional authorisation of the vaccine by the National Pharmaceutical Regulatory Agency (“NPRA”). (s) On 21 September 2021, MYDC, a wholly-owned subsidiary of the Company had entered into a shareholders’ agreement with the following parties to regulate the relationship of shareholders and other parties who will become shareholders of MYBB Techchain Sdn. Bhd. (“MYBB”) (now known as Zetrix Sdn. Bhd.): (i) Bubi Technologies Co Ltd (ii) Agmo Holdings Sdn. Bhd.; and (iii) Star Jewel Capital Inc. MYBB has been set up as a joint collaboration between MYDC and the parties which is intended to be principally involved in blockchain business development in and outside of Malaysia. (t) On 28 September 2021, MYEG Philippines, a joint venture company of the Company had rolled out two major e-government services, namely the online payment of income taxes to the Bureau of Internal Revenue and online payment of fees to the Philippine Economic Zone Authority. (u) On 12 October 2021, the Company entered into a MOU with the Institute of Industrial Internet and Internet of Things of the China Academy of Information and Communications Technology (“CAICT”) of China for the international extension of China’s national blockchain network, Xinghuo Blockchain Infrastructure and Facility (“Xinghuo BIF”), by introducing backbone and first supernodes outside China to be known as Zetrix. (v) On 18 October 2021, the Company proposed to undertake the issuance of up to 300,000,000 new MYEG Shares (“Placement Shares”) amounting to RM309.0 million (“Illustrative Proceeds”), representing up to about 4.17% of the total number of issued MYEG Shares (excluding treasury shares) (“Proposed Placement”). The remaining 100,000,000 new MYEG Shares which yet to be issued under the 2020 Placement will form part of the Proposed Placement, which will entail the issuance of up to 300,000,000 new MYEG Shares. The purposes for the new Placement Shares are as below:- (i) development of healthcare related services and healthcare related technology of RM60 million; (ii) development of Automated Training and Driving Test System (“e-Testing”) and purchase of hardware of RM60 million; (iii) development of blockchain products and services of RM175 million; (iv) working capital of RM7.7 million; and (v) expenses for the proposed placement estimated at RM6.3 million. On 29 October 2021, the Company further announced that the first tranche of the Placement has been completed following the listing and quotation of 210,000,000 new MYEG Shares on the Main Market of Bursa Securities fixed at issue price of RM1.02 per Placement Share. Total gross proceeds is amounted to RM214.2 million. (w) On 8 November 2021, the Company received the approval from Road Transport Department of Malaysia (“RTD”) to commence the Proof of Concept (“POC”) to set up an e-Testing to assess the competencies of candidates undergoing the Drivers’ Learning Education Curriculum.
RkJQdWJsaXNoZXIy NDgzMzc=